
Clonazepam
Clonazepam is a long-acting benzodiazepine for panic disorder and some seizure disorders. Two large placebo-controlled trials found it reduced panic attacks over 6 to 9 weeks, with 1 to 2 mg a day giving the best balance of benefit and side effects. The boxed warning covers opioids, abuse and addiction, and dependence with dangerous withdrawal. Cannabis is a high-severity supplement concern; passionflower and valerian are moderate ones.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with panic disorder, or adults and children with certain seizure disorders, treated by a prescriber
Common dosing range
Set by your prescriber. For panic disorder the label starts at 0.25 mg twice daily, with a target of 1 mg a day for most people and a maximum of 4 mg a day. For seizures in adults it starts at no more than 1.5 mg a day in three doses, up to a maximum of 20 mg a day
When to expect effects
Blood levels peak in 1 to 4 hours; the panic trials measured benefit after 6 to 9 weeks of treatment
Watch out for
Boxed warnings: profound sedation, slowed breathing, coma and death with opioids; abuse, misuse and addiction; and physical dependence, with withdrawal reactions that can be life-threatening if it is stopped suddenly or reduced quickly. Avoid alcohol. Contraindicated in significant liver disease and acute narrow-angle glaucoma.
What is it
Clonazepam is a prescription benzodiazepine and a Schedule IV controlled substance, sold as Klonopin and generic tablets. The Klonopin label approves it for panic disorder, with or without agoraphobia, in adults, and alone or as an add-on for certain seizure types (Lennox-Gastaut syndrome, akinetic and myoclonic seizures, and absence seizures that have not responded to succinimides). Like all benzodiazepines it carries a boxed warning about use with opioids, about abuse, misuse and addiction, and about dependence and withdrawal reactions. Because it is a long-acting sedative, cannabis, passionflower and valerian are the main supplement concerns, and the label also tells patients to avoid alcohol.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
panic disorder (short-term treatment) Good Evidence | Moderate in short trials; fewer panic attacks than placebo at 1 mg a day or more | Adults with panic disorder, with or without agoraphobia | Measured after 6 weeks at a stable dose |
panic disorder (benzodiazepines, pooled trials) Limited Evidence | Moderate in short trials; risk ratio 1.65 for response versus placebo | Adults with panic disorder in short-term treatment | Short-term trials of weeks |
panic disorder (short-term treatment)
- Effect
- Moderate in short trials; fewer panic attacks than placebo at 1 mg a day or more
- Best fit
- Adults with panic disorder, with or without agoraphobia
- Time
- Measured after 6 weeks at a stable dose
panic disorder (benzodiazepines, pooled trials)
- Effect
- Moderate in short trials; risk ratio 1.65 for response versus placebo
- Best fit
- Adults with panic disorder in short-term treatment
- Time
- Short-term trials of weeks
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
panic disorder (short-term treatment)
Disease adjunctIn a multicenter, fixed-dose trial, 413 people with panic disorder were randomized to placebo or clonazepam 0.5, 1, 2, 3 or 4 mg a day for 6 weeks after a 3-week dose increase. The published report found doses of 1 mg a day and higher equally effective at reducing panic attacks, 0.5 mg not clearly better than placebo, and 1 to 2 mg a day the best balance of benefit and tolerability; the Klonopin label's account of the same study says a significant difference from placebo was seen consistently only at 1 mg a day. A second trial of 438 adults using individually adjusted doses (0.25 to 4 mg a day) for 6 weeks found clonazepam better than placebo for the number of panic attacks, overall severity, phobic fear and avoidance, and anticipatory anxiety. Somnolence was the main side effect. In both trials a slow 7-week taper was tolerated, though symptoms partly returned.
Bottom line: In two large short trials, clonazepam at 1 mg a day or more reduced panic attacks compared with placebo.
Evidence is mixed
For the fixed-dose study, the published abstract reports 1 mg a day and higher as equally effective, while the Klonopin label says a significant difference from placebo was seen consistently only at 1 mg a day and that 2, 3 and 4 mg a day were less effective and caused more side effects.
panic disorder (benzodiazepines, pooled trials)
Disease adjunctA 2019 Cochrane review of 24 trials with 4,233 participants found benzodiazepines more likely than placebo to bring a response (risk ratio 1.65; about 4 people treated for one extra response) and remission (risk ratio 1.61), with fewer dropouts overall but more dropouts due to side effects (risk ratio 1.58). The reviewers rated the evidence low quality: the trials were short, often at high risk of bias, and did not examine dependence or withdrawal. They noted that guidelines recommend SSRI antidepressants first for panic disorder.
Bottom line: Pooled short trials suggest benzodiazepines help panic disorder, but the evidence is low quality.
Evidence is mixed
The reviewers note that guidelines recommend SSRI antidepressants first for panic disorder because of benzodiazepine dependence and withdrawal, which the pooled trials did not measure.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose and any taper; avoid alcohol, and treat sedating herbs and cannabis as extra sedatives.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: using benzodiazepines with opioids may result in profound sedation, respiratory depression, coma and death. The label reserves the combination for people whose other options are inadequate, at the lowest doses for the shortest time.
Boxed warning: abuse, misuse and addiction, which can lead to overdose or death. Abuse and misuse commonly involve other medicines, alcohol or illicit substances, which raises the risk of serious outcomes.
Boxed warning: dependence and withdrawal reactions. Continued use may lead to clinically significant physical dependence, with risk rising with longer use and higher doses. Abrupt stopping or rapid dose reduction may cause acute withdrawal reactions, including seizures, that can be life-threatening, and some people develop protracted withdrawal lasting weeks to more than 12 months.
Suicidal thoughts or behavior: as with all antiepileptic drugs, pooled trials showed about twice the risk seen with placebo (0.43% vs 0.24%).
Impaired thinking, driving and coordination; slowed breathing, especially in people with COPD or sleep apnea; more generalized tonic-clonic seizures in people with mixed seizure types (and absence status when combined with valproic acid); loss of anticonvulsant effect in up to 30% of initial responders; paradoxical reactions such as agitation and aggression; and sedation or withdrawal in newborns after use late in pregnancy.
Who should avoid it
- People with a history of sensitivity to benzodiazepines, clinical or laboratory evidence of significant liver disease, or acute narrow-angle glaucoma (contraindicated). People with open-angle glaucoma may use it if they are receiving appropriate treatment.
- People with lung disease such as COPD or sleep apnea, kidney impairment, porphyria, or difficulty handling saliva need caution; the label also advises periodic blood counts and liver tests during long-term treatment.
- Children and teens with panic disorder: the label says safety and effectiveness below age 18 have not been established for that use. People with a history of substance use disorder or depression need careful assessment and monitoring.
Pregnancy & breastfeeding
Pregnancy: the Klonopin label says newborns of mothers who used benzodiazepines late in pregnancy have had sedation (breathing problems, sluggishness, low muscle tone) and withdrawal symptoms, and that published observational studies do not report a clear link between benzodiazepines and major birth defects. In rabbit studies, clonazepam caused malformations at doses similar to or below human doses. Newborns exposed during pregnancy or labor should be watched for sedation, breathing problems, low muscle tone, feeding problems and withdrawal. The label encourages enrolling in the North American Antiepileptic Drug Pregnancy Registry. Breastfeeding: clonazepam passes into breast milk, and there are reports of sedation, poor feeding and poor weight gain in infants exposed to benzodiazepines through milk. The label says to weigh the benefits of breastfeeding against the mother's need for the medicine, and to watch a breastfed infant for sedation, poor feeding and poor weight gain.
Interactions
The Klonopin label tells patients to avoid alcohol and says alcohol may strengthen the sedating action of benzodiazepines; its Medication Guide warns that the combination can cause severe drowsiness, breathing problems, coma and death. Clonazepam's half-life is typically 30 to 40 hours, so the risk does not end when a dose wears off. No study has measured clonazepam with alcohol directly; the warning comes from the label. Ask your prescriber or pharmacist how this applies to you, do not stop clonazepam on your own to drink, and call emergency services for anyone who is hard to wake or breathing slowly.
Boxed warning: benzodiazepines with opioids may cause profound sedation, respiratory depression, coma and death. In a study of US veterans on opioid pain medicines, a current benzodiazepine prescription was linked to 3.86 times the risk of overdose death. The label limits the combination to people whose other options are inadequate, at the lowest doses for the shortest time.
Kavain, a main kava compound, strengthened GABA-A receptors in a lab study, the same calming system clonazepam acts on, so the two may add up to excessive sedation. A published case report describes coma in a patient who took kava with alprazolam, another benzodiazepine; no case with clonazepam itself has been published, and the Klonopin label does not name kava. Kava has also been linked to liver injury, and the label says clonazepam should not be used in significant liver disease. Avoid combining them unless your prescriber agrees, and do not stop clonazepam on your own to make room for an herb.
Cannabis can cause sedation and poor coordination, and the label for dronabinol, a prescription form of THC, lists benzodiazepines among drugs that add to its effect on driving and alertness. Direct evidence with clonazepam is lacking: in a lab study of 10 cannabis users, diazepam changed the effects of oral THC little, and CBD raised levels of the active metabolite of clobazam (another benzodiazepine) about 3-fold in the Epidiolex label, a CYP2C19 effect that may not apply to clonazepam. Do not drive after using both, and tell your prescriber about any cannabis or CBD use.
The Klonopin label says these drugs can strengthen the sedating action of benzodiazepines, and that using several anticonvulsants together can increase sedating side effects. Tell every prescriber and your pharmacist that you take clonazepam before anything sedating is added, including over-the-counter sleep aids.
Passionflower extract acted on the GABA system in lab and animal studies: its calming effect in mice was blocked by the benzodiazepine antagonist flumazenil, though in a test-tube study it did not bind the benzodiazepine site itself. A case report described tremor, dizziness and muscle fatigue in a man taking lorazepam, another benzodiazepine, with passionflower and valerian. Human evidence is limited, so treat it as a caution: the likely result is extra drowsiness. Ask your prescriber before using passionflower teas, supplements or sleep blends.
Valerenic acid from valerian strengthened GABA-A receptors in lab studies, so valerian may add to clonazepam's sedation. Human evidence is limited: a case report described tremor, dizziness and muscle fatigue in a man taking lorazepam with valerian and passionflower, while in 12 healthy volunteers 14 nights of valerian raised alprazolam's peak level only slightly without changing overall exposure. Treat valerian as a second sedative and use it only if your prescriber agrees.
The label says enzyme-inducing anticonvulsants lowered clonazepam levels by about 38%, and that oral antifungals and other CYP3A blockers should be used cautiously because they may raise clonazepam levels and effects. Clonazepam can also change phenytoin levels, so the label recommends monitoring them. Your prescriber decides on any dose change.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (3)
+ alcohol
criticalClonazepam (Klonopin) and alcohol both slow the brain and breathing, and the Klonopin label says alcohol can strengthen the sedating action of benzodiazepines. Its Medication Guide warns that benzodiazepines taken with alcohol can cause severe drowsiness, breathing problems, coma and death, and the label tells patients to avoid alcohol. The evidence is the FDA label and class warnings rather than a clonazepam plus alcohol study, and because clonazepam's half-life is typically 30 to 40 hours, the risk does not end when a dose wears off.
+ kava
highKavain, a main compound in kava, strengthened GABA-A receptors in a lab study, the same calming system clonazepam acts on, so the two may add up to excessive sedation. The only human report is a published case of coma in a patient who combined kava with alprazolam, another benzodiazepine; we found no case or study with clonazepam itself, and the Klonopin label does not name kava. Kava has also been linked to liver injury in a small number of reported cases.
+ passionflower
moderateClonazepam is a benzodiazepine that calms the brain by enhancing GABA, its main inhibitory neurotransmitter. Passionflower extract acted on the GABA system in lab and animal studies (its calming effect in mice was blocked by flumazenil, which blocks the benzodiazepine site), so it may add to clonazepam's sedation. The only human report is a case of tremor, dizziness and muscle fatigue in a man taking lorazepam, another benzodiazepine, with passionflower and valerian; no case with clonazepam has been published, so this is best treated as a caution rather than a proven hazard.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take passionflower or valerian with clonazepam?⌄
Ask your prescriber first. This page rates both moderate: each herb appears to act on the brain's GABA calming system, and a case report linked the pair to tremor and dizziness in a man taking lorazepam, another benzodiazepine. The likely result is extra drowsiness.
Is it safe to use cannabis or CBD with Klonopin?⌄
It is best avoided unless your prescriber agrees. Cannabis adds sedation and poor coordination, so do not drive after using both. Direct studies with clonazepam are lacking. Tell your prescriber about any cannabis or CBD use.
Can I drink alcohol while taking clonazepam?⌄
The Klonopin label says to avoid alcohol. Its Medication Guide warns that benzodiazepines taken with alcohol or other sedating drugs can cause severe drowsiness, breathing problems, coma and death.
How long does clonazepam stay in the body?⌄
Its elimination half-life is typically 30 to 40 hours, so it builds up over several days and wears off slowly. That is one reason sedation can carry into the next day, especially in older adults.
Can I stop taking clonazepam on my own?⌄
The boxed warning says abrupt stopping or a rapid dose reduction after continued use can cause withdrawal reactions, including seizures, that can be life-threatening. Your prescriber can plan a gradual taper if a change is needed.
References by claim
panic disorder (short-term treatment)
panic disorder (benzodiazepines, pooled trials)
Breilmann et al., 2019 · PMC (2019) link
Safety
Interaction: Kava (Piper methysticum)
Interaction: Cannabis and THC products
Interaction: Passionflower (Passiflora incarnata)
Interaction: Valerian (including valerian tea)
Interaction: Opioids (oxycodone, hydrocodone, codeine, tramadol, morphine, fentanyl, methadone, buprenorphine)
Park et al., 2015 · PMC (2015) link
Track Clonazepam with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
